This document is important and requires your immediate attention. If you are in any doubt as to the action you should take, you should seek advice from your investment consultant or other professional advisors.

This document has not been reviewed by the Central Bank of Ireland (the "Central Bank").

If you have sold or transferred all of your shares in the funds referred to below, please pass this document at once to the purchaser or transferee or to the stockbroker, bank or other agent through whom the sale or transfer was effected for transmission to the purchaser or transferee as soon as possible.

Capitalised terms used herein shall bear the same meaning as defined in the prospectus of Global X ETFs II ICAV (the "ICAV") dated 31 January 2024 (the "Prospectus") and the supplement in respect of the funds listed below dated 31 January 2024 (the "Supplements"). Copies of the Prospectus and Supplements are available upon request during normal business hours from the registered office of the ICAV.

18 July 2024

RE:   Notification of closure of the followings funds as defined below

Dear Investor,

We refer to the below sub-funds (together, the "Funds" and each, a "Fund") of the ICAV, of which you are an investor:

1.       Global X China Biotech UCITS ETF

2.       Global X China Clean Energy UCITS ETF

3.       Global X China Cloud Computing UCITS ETF.

Closure of the Funds

The purpose of this notice is to advise you of the closures of each of the Funds which is due to take place on 28 August 2024 (the "Closure Date"). 

In accordance with the provisions of the ICAV's instrument of incorporation and the Prospectus, the Directors have the discretion to effect the total repurchase of all of the shares in Funds. In light of prevailing market and economic conditions, the Directors have determined to compulsorily redeem the shares and close the Funds with effect from the Closure Date.

Procedure for Closure

For secondary market orders, the last day for trading on each relevant stock exchange on which the shares of the Funds are listed is 19 August 2024 (the "Final Exchange Dealing Date").

For primary market orders:

(i)         the last day on which applications for subscriptions for shares in the Funds by Authorised Participants may be made is 21 August 2024 (the "Final Subscription Dealing Date"); and 

(ii)        the last day on which applications for redemptions of shares in the Funds by Authorised Participants may be made is 23 August 2024 (the "Final Redemption Dealing Date"). 

The Funds will be de-listed from the stock exchanges on which the shares of the Funds are listed on  20 August 2024* (the "Delisting Date"). 23 August 2024 will be the final date on which the Funds will have exposure to the relevant index which it seeks to track or replicate.

*Please note that the delisting from the Official List of the Financial Conduct Authority ("FCA") date for the London Stock Exchange will be 20 August 2024.

On the Closure Date, all Shares will be compulsorily redeemed in accordance with the terms of the Prospectus and the redemption proceeds, calculated as of the Closure Date, will be remitted to investors of each Fund within the time period specified in each Fund's Supplement.

Investors buying and selling Shares through a broker or market maker/Authorised Participant and/or investors who hold Shares through a nominee and/or clearing agent, may not appear in the ICAV's register of Shareholders. Such investors should deal directly with the relevant broker, market maker/Authorised Participant, nominee or clearing agent (as relevant) in respect to of their investment.

A summary of the dealing, de-listing, closure and settlement dates is set out in Appendix 1.

Tax Considerations

The redemption of shares in the Funds will be deemed a disposal for capital gains tax purposes and may give rise to a capital gains tax liability. If you are in any doubt as to the tax consequences, you should contact your financial or tax advisor.

Yours faithfully,

_______________

Director

For and on behalf of

Global X ETFs II ICAV

Appendix I